Trevi Therapeutics TRVI SEC Filings

NASDAQ TRVI
$14.91 -0.40 (-2.61%)
At close: Nov 10, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Trevi Therapeutics, Inc. (TRVI) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001193125-26-453674Nov 9, 2026 9:27 PM
28-KCurrent Report0001193125-26-453670Nov 9, 2026 9:26 PM
3SCHEDULE 13GBeneficial Ownership Report0002012383-26-003855Oct 27, 2026 9:25 PM
44Insider Transaction0001193125-26-394456Sep 17, 2026 8:55 PM
5144Insider Transaction0001950047-26-009512Sep 15, 2026 8:42 PM
6S-8Prospectus0001193125-26-338071Aug 6, 2026 8:16 PM
710-QQuarterly & Annual Report0001193125-26-338023Aug 6, 2026 8:12 PM
88-KCurrent Report0001193125-26-337974Aug 6, 2026 8:08 PM
9SCHEDULE 13GBeneficial Ownership Report0000315066-26-002184Aug 6, 2026 2:43 PM
104Insider Transaction0001193125-26-257488Jun 4, 2026 8:28 PM
118-KCurrent Report0001193125-26-257365Jun 4, 2026 8:05 PM
124Insider Transaction0001193125-26-257370Jun 4, 2026 8:05 PM
134Insider Transaction0001193125-26-257373Jun 4, 2026 8:05 PM
144Insider Transaction0001193125-26-257371Jun 4, 2026 8:05 PM
154Insider Transaction0001193125-26-257366Jun 4, 2026 8:05 PM
16SCHEDULE 13DBeneficial Ownership Report0001072613-26-000382May 7, 2026 10:23 PM
17SCHEDULE 13GBeneficial Ownership Report0000315066-26-001314May 6, 2026 3:40 PM
1810-QQuarterly & Annual Report0001193125-26-206390May 5, 2026 8:09 PM
198-KCurrent Report0001193125-26-206382May 5, 2026 8:07 PM
20DEF 14AOthers0001193125-26-166695Apr 21, 2026 8:00 PM
21DEFA14AOthers0001193125-26-166693Apr 21, 2026 8:00 PM
22ARSOthers0001193125-26-166694Apr 21, 2026 8:00 PM
23424B5Prospectus0001193125-26-161582Apr 17, 2026 8:17 PM
248-KCurrent Report0001193125-26-160355Apr 17, 2026 12:06 PM
25424B5Prospectus0001193125-26-159041Apr 16, 2026 8:16 PM
26PRE 14AOthers0001193125-26-151354Apr 10, 2026 8:32 PM
27SCHEDULE 13GBeneficial Ownership Report0000102909-26-002401Mar 27, 2026 5:31 PM
2810-KQuarterly & Annual Report0001193125-26-110783Mar 17, 2026 8:08 PM
298-KCurrent Report0001193125-26-110767Mar 17, 2026 8:07 PM
308-KCurrent Report0001193125-26-098676Mar 9, 2026 8:35 PM
314Insider Transaction0001193125-26-061399Feb 20, 2026 9:17 PM
324Insider Transaction0001193125-26-061396Feb 20, 2026 9:16 PM
334Insider Transaction0001193125-26-061394Feb 20, 2026 9:16 PM
344Insider Transaction0001193125-26-061391Feb 20, 2026 9:16 PM
354Insider Transaction0001193125-26-061385Feb 20, 2026 9:15 PM
365Insider Transaction0001193125-26-051530Feb 13, 2026 9:30 PM
375Insider Transaction0001193125-26-051548Feb 13, 2026 9:30 PM
385Insider Transaction0001193125-26-051545Feb 13, 2026 9:30 PM
395Insider Transaction0001193125-26-051528Feb 13, 2026 9:30 PM
405Insider Transaction0001193125-26-051525Feb 13, 2026 9:30 PM
415Insider Transaction0001193125-26-051520Feb 13, 2026 9:30 PM
425Insider Transaction0001193125-26-051537Feb 13, 2026 9:30 PM
435Insider Transaction0001193125-26-051517Feb 13, 2026 9:30 PM
44SCHEDULE 13GBeneficial Ownership Report0001104659-26-015247Feb 13, 2026 9:26 PM
45SCHEDULE 13DBeneficial Ownership Report0001072613-26-000150Feb 13, 2026 9:05 PM
46SCHEDULE 13GBeneficial Ownership Report0000315066-26-000550Feb 5, 2026 6:40 PM
47SCHEDULE 13GBeneficial Ownership Report0000102909-26-000259Jan 30, 2026 7:43 PM
484Insider Transaction0001193125-26-010361Jan 12, 2026 9:05 PM
493Insider Transaction0001193125-26-010351Jan 12, 2026 9:03 PM
508-KCurrent Report0001193125-25-308769Dec 5, 2025 1:58 PM
...

Trevi Therapeutics, Inc. SEC Filings API

Pull Trevi Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=TRVI&formtype=10-K,10-Q&api_key=YOUR_API_KEY